Aeglea BioTherapeutics, Inc. Human Resources Contracts & Agreements
30 Contracts & Agreements
- Bonus & Incentive Agreements (13 contracts)
- Consulting Agreements (6)
- Employment Agreements (1)
- Severance Agreements (10)
- Form of Stock Option Agreement under the Amended and Restated Spyre Therapeutics, Inc. 2016 Equity Incentive Plan (Filed With SEC on August 7, 2024)
- Consulting Agreement by and between the Company and Mark McKenna, effective August 1, 2023 (Filed With SEC on March 1, 2024)
- Consulting Agreement by and between the Company and Mark McKenna, effective August 1, 2023 (Filed With SEC on February 29, 2024)
- Separation and Consulting Agreement and General Release of Claims by and between the Company and Jonathan Alspaugh, dated as of September 22, 2023 (Filed With SEC on December 22, 2023)
- Form of Severance Agreement (Filed With SEC on December 22, 2023)
- Spyre Therapeutics, Inc. 2023 Equity Incentive Plan (Filed With SEC on December 22, 2023)
- Spyre Therapeutics, Inc. 2016 Equity Incentive Plan, As Amended and Restated Effective November 21, 2023 (Filed With SEC on December 22, 2023)
- 2015 Equity Incentive Plan and forms of award agreements (Filed With SEC on December 22, 2023)
- Separation and Consulting Agreement and General Release of Claims by and between the Company and Jonathan Alspaugh, dated as of September 22, 2023 (Filed With SEC on November 15, 2023)
- Form of Severance Agreement (Filed With SEC on November 15, 2023)
- Amended and Restated Spyre 2023 Equity Incentive Plan (Filed With SEC on November 15, 2023)
- First Amendment to the Aeglea BioTherapeutics, Inc. 2016 Equity Incentive Plan (Filed With SEC on November 15, 2023)
- 2016 Equity Incentive Plan and forms of award agreements, as amended (Filed With SEC on November 15, 2023)
- 2015 Equity Incentive Plan and forms of award agreements (Filed With SEC on November 15, 2023)
- Separation and Consulting Agreement and General Release of Claims by and between the Company and Jonathan Alspaugh, dated as of September 22, 2023 (Filed With SEC on September 25, 2023)
- Amended and Restated Spyre 2023 Equity Incentive Plan (Filed With SEC on August 11, 2023)
- First Amendment to the Aeglea BioTherapeutics, Inc. 2016 Equity Incentive Plan (Filed With SEC on August 11, 2023)
- Severance Agreement dated July 6, 2021 by and between the Registrant and Mr. Jonathan Alspaugh (Filed With SEC on March 8, 2022)
- Severance Agreement dated August 7, 2019 by and between the Registrant and Dr. Leslie Sloan (Filed With SEC on May 7, 2020)
- Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on November 8, 2018)
- Severance Agreement, dated July 18, 2018 by and between the Company and Anthony G. Quinn (Filed With SEC on July 23, 2018)
- Form of Severance Agreement (Filed With SEC on April 16, 2018)
- Vice President of Finance Severance Agreement (Filed With SEC on March 23, 2017)
- AEGLEA BIOTHERAPEUTICS, INC. 2016 EQUITY INCENTIVE PLAN (Filed With SEC on March 28, 2016)
- VICE PRESIDENT SEVERANCE AGREEMENT (Filed With SEC on March 14, 2016)
- VICE PRESIDENT SEVERANCE AGREEMENT (Filed With SEC on September 14, 2015)
- VICE PRESIDENT SEVERANCE AGREEMENT (Filed With SEC on September 14, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on September 14, 2015)
- CONSULTING AGREEMENT (Filed With SEC on June 16, 2015)
- AEGLEA BIOTHERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN As Adopted on March 10, 2015 (Filed With SEC on June 16, 2015)
